Innehållet på denna webbplats är endast avsett för veterinärer eller andra professionella inom djurhälsovård.
Genom att använda denna webbplats accepterar du ovanstående.
Intervacc expands the distribution agreement with Animalcare Group plc
The animal health company Intervacc has through the wholly owned subsidiary Nordvacc Läkemedel AB (Nordvacc) expanded the distribution agreement with Ecuphar NV, a wholly owned subsidiary of Animalcare Group plc, a European company Headquartered in the UK. The...The manufacturing process for Strangvac is proceeding according to plan
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in compliance with GMP (Good Manufacturing Practice). “We are very pleased to...Intervacc AB and the Swedish University of Agricultural Sciences, SLU, sign a multi-year contract for the development of innovative animal health vaccines
Intervacc AB and the Swedish University of Agricultural Sciences, SLU, have signed a multi-year contract for the development of a new generation of animal health vaccines using recombinant proteins. The contract is a continuation and expansion of the very successful...Update of contact information for Certified Adviser for previous Press Release – Large-scale manufacturing process for Strangvac now secured
Update of previous Press Release distributed April 1, 2019: Contact information for Certified Adviser added. Otherwise no changes. The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured...Large-scale manufacturing process for Strangvac now secured
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the vaccine against equine strangles. The technology transfer of manufacturing and the verification of...Nyhetstjänster
